You are here: Industry Insights > COVID-19

News List

Researchers identify immune system variation linked to severe COVID-19 cases expresspharma
July 29, 2020
The current study found that one risk factor was the presence of an immune system molecule called alpha interferon-a cytokine mobilised to combat viral pathogens such as the flu virus.
Gov unveils new anti-obesity measures pharmatimes
July 28, 2020
The government has revealed a package of new measures falling under its new Obesity Strategy that are designed to improve health, ease the related burden on the NHS, and strengthen the public's resilience to COVID-19.
Pfizer and BioNTech select lead mRNA vaccine against COVID-19 pharmatimes
July 28, 2020
Pfizer and BioNTech have started a global Phase II/III safety and efficacy clinical study to evaluate a single nucleoside-modified messenger RNA (modRNA) candidate from their BNT162 mRNA-based vaccine programme against SARS-CoV-2.
Moderna Announces Start of Phase 3 COVE Study of mRNA Vaccine against COVID-19 americanpharmaceuticalreview
July 28, 2020
Moderna has announced that the Phase 3 study of its mRNA vaccine candidate (mRNA-1273) against COVID-19 has begun dosing participants.
FDA Clears Abivertinib for Safety, Efficacy Study in COVID-19 Hospitalized Patients americanpharmaceuticalreview
July 28, 2020
Sorrento Therapeutics received clearance from the FDA to initiate a Phase 2 trial of Abivertinib in patients with COVID-19 who have moderate to severe pulmonary symptoms.
Biocon’s itolizumab fails to be part of Covid-19 management protocols pharmaceutical-technology
July 28, 2020
The National Task Force for Covid-19 in India has denied the inclusion of Biocon’s itolizumab in its clinical management protocols for the disease.
Argonaut Expands Capacity for COVID-19 Viral Transport Media Filling contractpharma
July 28, 2020
New capacity will serve unmet need in COVID-19 testing infrastructure.
Franco Negron Named CEO of ApiJect Systems America contractpharma
July 28, 2020
Leading pharma executive joins company at the center of U.S. and global COVID-19 response.
U.S. Invests $472mn More in Moderna contractpharma
July 28, 2020
Expansion of BARDA deal supports mRNA-1273 clinical development plan including 30,000 participant Phase 3 COVE study conducted in collaboration with NIH.
Number of US COVID-19 clinical trials surpasses China: GlobalData expresspharma
July 28, 2020
Clinical trials in India also growing at a higher rate, and the country is now in fourth place for COVID-19 trials.